Optimizing CAR T-Cell Therapy in DLBCL With Community and Academic Perspectives - Episode 3
Selecting Candidates for CAR T-Cell Therapy in R/R DLBCL: Patient Characteristics, Eligibility, and Timing Considerations
Experts discuss the patient factors and disease characteristics that influence the selection of chimeric antigen receptor T-cell therapy (CAR T) options, how to determine if a patient is an appropriate candidate, and when to begin considering CAR T in the treatment journey.
Video Player is loading.
Video content above is prompted by the following:
- What patient factors and/or disease characteristics influence your decision when selecting among the currently available CAR T options?
- How do you determine if a patient is an appropriate candidate for CAR T?
- At what point in the treatment journey do you begin considering CAR T?
Related Content:
